It was also found that PPAR-γ agonists were able to ameliorate learning and memory deficits in a mouse model of dementia by increasing the expression of low-density lipoprotein receptor-related protein 1 (LRP1) in the hippocampus (143). Here, LRP1 is linked to dementia.